Navigation Links
Par Pharmaceutical Companies Reports Third Quarter 2011 Results
Date:11/2/2011

TSCurrent assets:Cash and cash equivalents$225,969$218,674Available for sale marketable debt securities30,86127,866Accounts receivable, net  98,10395,705Inventories80,98672,580Prepaid expenses and other current assets22,53717,660Deferred income tax assets31,00526,037Income taxes receivable37,86418,605Total current assets527,325477,127Property, plant and equipment, net69,66571,980Intangible assets, net63,42495,467Goodwill63,72963,729Other assets6,4955,441Non-current deferred income tax assets, net55,45169,488Total assets$786,089$783,232LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$21,551$23,956Payables due to distribution agreement partners53,47325,310Accrued salaries and employee benefits 11,66016,397Accrued government pricing liabilities39,82432,169Accrued legal fees7,2967,084Accrued legal settlements37,800-Accrued expenses and other current liabilities6,0566,674Total current liabilities177,660111,590Long-term liabilities44,79143,198Commitments and contingencies--Stockholders' equity:Common Stock, par value $0.01 per share, authorized 90,000,000 shares; issued39,662,618 and 38,872,663 shares394389Additional paid-in capital394,468373,764Retained earnings251,140329,129Accumulated other comprehensive (loss) income(21)137Treasury stock, at cost 3,180,643 and 2,970,573 shares(82,343)(74,975)Total stockholders' equity563,638628,444Total liabilities and stockholders' equity$786,089$783,232PAR PHARMACEUTICAL COMPANIES, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In Thousands, Except Per Share Data)

(Unaudited)Three months endedNine months endedSeptember 30,September 30,September 30,September 30,2011201020112010Revenues:Net product sales

$208,865$226,131$644,672$763,148Other product related revenues

6,4928,30927,82518,698Total revenues

215,357234,440672,497781,846Cost of goods sold

130,253131,146378,714503,583Gross margin

85,104103,294293,783278,263Operating expenses:Research and development'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
(Date:1/14/2014)... 2014 Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company ... Progressive Home Medical Equipment, Inc. ("Progressive") of Clarion, ... the acquisition were not disclosed. Progressive is ... wide range of sleep, mobility, and respiratory products to customers ...
(Date:1/14/2014)... , a manufacturer of ergonomically designed laboratory equipment for ... Japan to sell and service the Hitachi ... will utilize its network of sales professionals throughout the ... offer assistance in application use, product benefits and features, options and ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
(Date:4/17/2014)... a review published in the April issue of ... Feinstein Institute for Medical Research, says it,s time to ... approach to treating sepsis, which kills millions worldwide ... occurs when molecules released into the bloodstream to fight ... Inflammation is necessary for maintaining good health without ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... (BUSM) have discovered that the anti-seizure drug ezogabine, ... findings, reported in the American Journal of ... more effective treatments for alcoholism. , Excessive consumption ... of illness and death in the U.S. and ... productivity of workers and necessitating huge health care ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... and director of the Walter and Eliza Hall Institute, ... Australia Leadership and Innovation Award. The award recognises ... as his leadership in promoting the value of health ... Hilton,s scientific career has focussed on the control of ...
... , WEDNESDAY, Nov. 16 (HealthDay News) -- Overall outpatient ... 12 percent between 1999 and 2007, but alarmingly high ... antibiotic-resistant bacteria, researchers warn. The findings were ... Center for Disease Dynamics, Economics & Policy in Washington, ...
... cardiovascular disease who have a genetic variation that diminishes ... standard daily dosage of this medication resulted in improved ... JAMA . The study is being released early online ... Association Scientific Sessions. "Variants in the CYP2C19 ...
... tolerability of the breast cancer drug tamoxifen in male breast ... therapy early because of problems with side effects caused by ... published today in the cancer journal Annals of Oncology ... patients at their institution who had received tamoxifen for an ...
... New York State Senator Jeffrey ... Albert Einstein College of Medicine of Yeshiva University last ... Neurophysiology Laboratory . Several pieces of high-tech diagnostic and ... equipment and specialized video recording devices, were purchased through ...
... By Denise Mann HealthDay Reporter , TUESDAY, Nov. ... at higher risk than brainiacs for later weight gain and added ... had the lowest IQs at about age 18 had higher waist-to-hip ... those IQ tests. It,s known that people with "apple-shaped" bodies, or ...
Cached Medicine News:Health News:Professor Doug Hilton wins Research Australia Award 2Health News:Increasing dosage of clopidogrel for patients with genetic variation improves response to medication 2Health News:Male breast cancer patients stop taking tamoxifen early because of drug-related side effects 2Health News:Male breast cancer patients stop taking tamoxifen early because of drug-related side effects 3Health News:State Sen. Jeff Klein launches Einstein's new lab 2Health News:Study Finds Link Between Low IQ, Large Waistline 2Health News:Study Finds Link Between Low IQ, Large Waistline 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: